Related Experiment Video
Updated: Aug 16, 2025

Inducing Myointimal Hyperplasia Versus Atherosclerosis in Mice: An Introduction of Two Valid Models
Published on: May 14, 2014
Statins Show Anti-Atherosclerotic Effects by Improving Endothelial Cell Function in a Kawasaki Disease-like
Yusuke Motoji1, Ryuji Fukazawa2, Ryosuke Matsui2
1Department of Cardiovascular Surgery, Nippon Medical School Hospital, 1-1-5 Sendagi, Bunkyo-ku, Tokyo 113-8603, Japan.
Insights
Kawasaki disease (KD) causes vascular inflammation and damage. Statins may prevent cardiovascular issues by restoring endothelial cell function and nitric oxide synthase expression in KD patients.
Area of Science:
- Cardiovascular Science
- Immunology
- Pharmacology
Background:
- Kawasaki disease (KD) is an acute inflammatory syndrome linked to cardiovascular complications.
- Chronic KD-induced vasculitis may lead to atherosclerosis in young adults via cellular senescence and endothelial damage.
Purpose of the Study:
- To investigate the impact of KD and statin treatment on vascular cellular senescence and endothelial cells.
- To assess statins' potential in mitigating KD-related vascular damage.
Main Methods:
- Kawasaki disease-like vasculitis was induced in apolipoprotein E-deficient mice using Candida albicans water-soluble fraction (CAWS).
- Mice were divided into control, CAWS, and CAWS+statin groups.
- Aortic tissues were analyzed for endothelial nitric oxide synthase (eNOS) expression and cellular senescence markers.
Main Results:
- KD-like vasculitis impaired eNOS-producing vascular endothelial cells and increased macrophage infiltration.
- Statins treatment restored endothelial cell function by enhancing eNOS expression.
- Cellular senescence markers were modulated by KD and statin treatment.
Conclusions:
- KD-induced vasculitis damages vascular endothelial cells and promotes inflammation.
- Statins demonstrate potential in restoring endothelial function and may prevent chronic cardiovascular events post-KD.
Abstract:
Kawasaki disease (KD) is an acute inflammatory syndrome of unknown etiology that is complicated by cardiovascular sequelae. Chronic inflammation (vasculitis) due to KD might cause vascular cellular senescence and vascular endothelial cell damage, and is a potential cause of atherosclerosis in young adults. This study examined the effect of KD and HMG-CoA inhibitors (statins) on vascular cellular senescence and vascular endothelial cells. Candida albicans water-soluble fraction (CAWS) was administered intraperitoneally to 5-week-old male apolipoprotein E-deficient (ApoE-) mice to induce KD-like vasculitis. The mice were then divided into three groups: control, CAWS, and CAWS+statin groups. Ten weeks after injection, the mice were sacrificed and whole aortic tissue specimens were collected. Endothelial nitric oxide synthase (eNOS) expression in the ascending aortic intima epithelium was evaluated using immunostaining. In addition, eNOS expression and levels of cellular senescence markers were measured in RNA and proteins extracted from whole aortic tissue. KD-like vasculitis impaired vascular endothelial cells that produce eNOS, which maintains vascular homeostasis, and promoted macrophage infiltration into the tissue. Statins also restored vascular endothelial cell function by promoting eNOS expression. Statins may be used to prevent secondary cardiovascular events during the chronic phase of KD.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Atherosclerosis I: Introduction

